What is the treatment for nephrolithiasis (kidney stones)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Nephrolithiasis (Kidney Stones)

The first-line treatment for nephrolithiasis is increased fluid intake to achieve at least 2 liters of urine output per day, with pharmacologic therapy (thiazide diuretics, citrate, or allopurinol) recommended when fluid therapy fails to prevent stone recurrence. 1, 2

Non-Pharmacological Management

Fluid Intake

  • Increased fluid intake to achieve at least 2-2.5 L of urine output daily is the cornerstone of treatment for preventing kidney stone recurrence 1, 2, 3
  • Fluid intake should be balanced between day and night to avoid urinary supersaturation during nighttime 3
  • Water is the preferred fluid, with no significant difference between tap water and mineral water 2
  • A high fluid intake reduces stone recurrence risk by approximately 50% compared to no treatment 1

Dietary Modifications

  • Reduce consumption of soft drinks acidified by phosphoric acid (colas) 2, 1
  • Maintain normal dietary calcium intake rather than restricting it, as calcium restriction may actually increase stone risk 2, 4
  • Moderate dietary salt restriction helps limit urinary calcium excretion 4
  • Low-normal protein intake decreases calciuria and could be useful in stone prevention 4
  • Increased intake of fruits and vegetables (except those high in oxalate) increases citrate excretion and provides protection against stone formation 4

Pharmacological Management

When increased fluid intake fails to prevent stone formation, pharmacologic therapy should be initiated based on stone type and metabolic abnormalities:

For Calcium Stones (80% of all kidney stones)

  • Thiazide diuretics (e.g., hydrochlorothiazide, chlorthalidone, indapamide) reduce calcium stone recurrence by approximately 50% and are particularly beneficial for patients with hypercalciuria 1, 2, 5
  • Citrate therapy (potassium citrate) reduces calcium stone recurrence by about 75% by binding to calcium and decreasing urine acidity 1, 2
  • Allopurinol reduces stone recurrence by approximately 40% and is most beneficial for patients with hyperuricemia or hyperuricosuria 1, 2

For Uric Acid Stones

  • Allopurinol is recommended for patients with hyperuricosuria 5, 4
  • Potassium citrate to alkalinize urine 5

Treatment Algorithm

  1. First-line treatment for all stone types:

    • Increase fluid intake to achieve at least 2 L of urine output daily 1, 2
    • Implement appropriate dietary modifications based on stone type 2, 4
  2. If fluid therapy fails (continued stone formation):

    • For calcium stones with hypercalciuria: Thiazide diuretic 1, 2
    • For calcium stones with hypocitraturia: Potassium citrate 2, 5
    • For calcium stones with hyperuricosuria: Allopurinol 1, 2
    • For uric acid stones: Allopurinol and potassium citrate 5, 4

Important Considerations

  • Monotherapy is generally as effective as combination therapy for preventing stone recurrence 2
  • Higher doses of thiazides are associated with more adverse effects but have better-established effectiveness in preventing stone recurrence than lower doses 5
  • A randomized prospective 5-year study showed that high water intake alone reduced recurrence rates from 27% to 12% and extended the average time to recurrence from 25 months to 39 months 6
  • Although biochemical testing is commonly used to guide treatment selection, randomized controlled trial evidence supporting this approach is limited 2, 5
  • Patient compliance with increased fluid intake can be challenging and requires practical strategies and daily routines to ensure adequate hydration 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nephrolithiasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2015

Guideline

Management of Abnormal Urinalysis in Patients with Nephrolithiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.